Search
Last update: : 01.07.2025
Hintergrund Darmkrebs ist und bleibt eine der häufigsten Krebsarten und ist darüber hinaus für einen Großteil der krebsbedingten Todesfälle verantwortlich. In Deutschland steht Darmkrebs…
Last update: : 01.07.2025
2017 Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J,…
Last update: : 01.07.2025
COSIMO COSIMO is the acroynm for Colorectal Cancer Multi-State Simulation Model, an in-house developed tool for the population-wide prediction of colorectal cancer incidence and mortality.…
Last update: : 01.07.2025
Publications 2025 Publications 2024 Publications 2023 Publications 2022 Publications 2021 Publications 2020 Publications…
Last update: : 01.07.2025
Awards 2024 T. Heisser, M. Hoffmeister, H. Brenner. Felix Burda Award 2024, Kategorie Medizin und Wissenschaft 2023 X. Chen, Chinese Government Award for Outstanding Self-financed Students…
Last update: : 01.07.2025
Colorectal cancer accounts for more than 60,000 new cases and more than 25,000 deaths per year in Germany. The prognosis has particularly improved for earlier stages of the disease. However,…
Last update: : 01.07.2025
Lower gastrointestinal symptom burden by prophylaxis with synbiotics after colorectal cancer surgery (LEONORA) A key component of colorectal cancer treatment is the surgical resection of the…
Last update: : 01.07.2025
In Germany, there are more than 60,000 new cases of colorectal cancer and more than 25,000 deaths from colorectal cancer per year. Although the prognosis has particularly improved for the early…
Last update: : 01.07.2025
Lung cancer is the leading cause of death from cancer, and accounts for approximately 1.8 million deaths each year. Survival of lung cancer patients heavily depends on stage of diagnosis.…
Last update: : 01.07.2025
Polypharmacy (5 or more medications used simultaneously) is very common in elderly cancer patients. For example, one in two colorectal cancer patients aged 65 or older is affected by polypharmacy.…